Department of Urology, University of Alabama , Birmingham, United Kingdom.
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Curr Opin Urol. 2021 May 1;31(3):214-219. doi: 10.1097/MOU.0000000000000871.
To review the current literature and guidelines regarding salvage therapy for local and regional recurrence of primary penile cancer.
While invasive surgical management has not significantly changed, penile sparing treatments (PSTs) may have a promising role in the management of local recurrence. Penile sparing surgeries do appear to have higher rates of recurrence. However, the overall survival rate is comparable to that of partial and total penectomies. Additionally, a combination of therapies may have a more profound effect on management of penile cancer.
Clinicians must discuss the role of each type of therapy for penile cancer with their patients, and tailor their management to the extent of disease in each patient. While it is important to discuss the balance between quality of life and rates of relapse, one must also emphasize the rates of overall survival in patients with local recurrence who are treated with PSTs.
回顾原发性阴茎癌局部和区域性复发的挽救性治疗的当前文献和指南。
虽然侵袭性手术管理没有明显改变,但保阴茎治疗(PST)在局部复发的管理中可能具有有前途的作用。保阴茎手术的复发率似乎确实更高。然而,总生存率与部分和全阴茎切除术相当。此外,联合治疗可能对阴茎癌的治疗有更深远的影响。
临床医生必须与患者讨论每种类型的阴茎癌治疗方法的作用,并根据每位患者疾病的严重程度调整治疗方案。虽然讨论生活质量与复发率之间的平衡很重要,但也必须强调接受 PST 治疗的局部复发患者的总体生存率。